Criteria for who should get heart surgery and when are based primarily on research in men, but two studies suggest this leads ...

Edwards Lifesciences (NYSE: EW) and Boston Scientific (NYSE: BSX) both reported strong quarters, but the results reveal ...

EW gears up for Q4 earnings as investors watch TAVR momentum, fast-growing TMTT sales and steady surgical heart demand.

In January, Mount Carmel East hospital opened a new hybrid cardiovascular operating room as part of their ongoing commitment ...

Edwards Lifesciences Corporation (NYSE:EW) is a medical technology company that develops and provides patient-focused innovations for heart conditions, specializing in structural heart disease ...

BACKGROUND: Recent randomized trials have demonstrated that for patients with severe tricuspid regurgitation (TR), transcatheter tricuspid valve interventions (TTVI) improve patients’ symptoms, ...

Abbott (NYSE: ABT) has reported new data supporting its Tendyne transcatheter mitral valve replacement (TMVR) system.

Doctors at Oklahoma Heart Institute are now offering a newly FDA-approved heart valve replacement that requires no open-heart ...

Many heart procedures are labeled as “minimally invasive,” but some of these procedures still involve cutting through the ...

The vertebrate heart is a highly modified muscular vessel, which is composed of numerous cell lineages. Heart patterning is a complex and spatially and temporally dynamic process. The cardiac ...